RECRUITING

Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

People with PD have lower cardiopulmonary function than their age matched peers. This decline can further impair a person's ability to participate in exercise and daily activities. Furthermore, the limitations in cardiopulmonary function can have a severe impact on mortality. There is evidence indicating the positive changes IMT can have on cardiopulmonary function in people with PD. Through intensive daily exercise people with PD have shown improvements in maximum inspiratory pressure and maximum expiratory pressure though detraining does occur when the intervention is not continued. The purpose of the proposed study is to determine if improvements in expiratory muscle strength can be maintained with a maintenance inspiratory muscle training program. The hypothesis is that there will be a significant change from baseline at the three and six month follow ups.

Official Title

The Impact of a Customized Respiratory Muscle Training and Maintenance Program on Cardiopulmonary Function in People With Parkinson's Disease.

Quick Facts

Study Start:2022-11-01
Study Completion:2023-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05287243

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * physician's diagnosis of Parkinson's disease
  1. * people who are actively smoking, have a pacemaker, recent diagnosis of chronic obstructive pulmonary disease, bronchial asthma, active pulmonary disease within 1 month, or hospitalization within 2 months of time of study

Contacts and Locations

Study Contact

Kristen Barta, DPT, PhD
CONTACT
737-202-3341
kbarta@usa.edu
Elizabeth Ardolino, PT, PhD
CONTACT
737-202-3343
eardolino@usa.edu

Principal Investigator

Kristen Barta, PT, PhD
PRINCIPAL_INVESTIGATOR
The University of St. Augustine for Health Sciences

Study Locations (Sites)

University of St. Augustine for Health Sciences
Austin, Texas, 78739
United States

Collaborators and Investigators

Sponsor: University of St. Augustine for Health Sciences

  • Kristen Barta, PT, PhD, PRINCIPAL_INVESTIGATOR, The University of St. Augustine for Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-01
Study Completion Date2023-12-01

Study Record Updates

Study Start Date2022-11-01
Study Completion Date2023-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease